1. Home
  2. BDTX vs ATLO Comparison

BDTX vs ATLO Comparison

Compare BDTX & ATLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDTX
  • ATLO
  • Stock Information
  • Founded
  • BDTX 2014
  • ATLO 1903
  • Country
  • BDTX United States
  • ATLO United States
  • Employees
  • BDTX N/A
  • ATLO N/A
  • Industry
  • BDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • ATLO Major Banks
  • Sector
  • BDTX Health Care
  • ATLO Finance
  • Exchange
  • BDTX Nasdaq
  • ATLO Nasdaq
  • Market Cap
  • BDTX 220.3M
  • ATLO 180.3M
  • IPO Year
  • BDTX 2020
  • ATLO N/A
  • Fundamental
  • Price
  • BDTX $3.95
  • ATLO $21.00
  • Analyst Decision
  • BDTX Strong Buy
  • ATLO
  • Analyst Count
  • BDTX 5
  • ATLO 0
  • Target Price
  • BDTX $10.40
  • ATLO N/A
  • AVG Volume (30 Days)
  • BDTX 812.4K
  • ATLO 22.9K
  • Earning Date
  • BDTX 11-05-2025
  • ATLO 10-17-2025
  • Dividend Yield
  • BDTX N/A
  • ATLO 3.81%
  • EPS Growth
  • BDTX N/A
  • ATLO 82.22
  • EPS
  • BDTX 0.25
  • ATLO 1.79
  • Revenue
  • BDTX $70,000,000.00
  • ATLO $60,568,000.00
  • Revenue This Year
  • BDTX N/A
  • ATLO N/A
  • Revenue Next Year
  • BDTX N/A
  • ATLO N/A
  • P/E Ratio
  • BDTX $15.76
  • ATLO $11.64
  • Revenue Growth
  • BDTX N/A
  • ATLO 18.60
  • 52 Week Low
  • BDTX $1.20
  • ATLO $15.75
  • 52 Week High
  • BDTX $4.45
  • ATLO $21.48
  • Technical
  • Relative Strength Index (RSI)
  • BDTX 55.41
  • ATLO 58.98
  • Support Level
  • BDTX $3.71
  • ATLO $20.65
  • Resistance Level
  • BDTX $4.08
  • ATLO $21.00
  • Average True Range (ATR)
  • BDTX 0.24
  • ATLO 0.42
  • MACD
  • BDTX -0.04
  • ATLO 0.05
  • Stochastic Oscillator
  • BDTX 35.90
  • ATLO 75.79

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

About ATLO Ames National Corporation

Ames National Corporation is a United States-based bank holding company. It provides short-term and medium-term commercial, multi-family, and agricultural real estate loans, residential real estate loans, agricultural and business operating loans and lines of credit, equipment loans, vehicle loans, personal loans and lines of credit, home improvement loans and origination of mortgage loans for sale into the secondary market. The Banks also offer a variety of checking, savings and time deposits, cash management services, merchant credit card processing, safe deposit boxes, wire transfers, direct deposit and automated/video teller machine access. The banking segment generates revenues through personal, business, agricultural and commercial lending, and Others.

Share on Social Networks: